Mutations in the MepRAB efflux system contribute to the in vitro development of tigecycline resistance in Staphylococcus aureus.

MLA

Fang, Renchi, et al. “Mutations in the MepRAB Efflux System Contribute to the in Vitro Development of Tigecycline Resistance in Staphylococcus Aureus.” Journal of Global Antimicrobial Resistance, vol. 22, Sept. 2020, pp. 631–36. EBSCOhost, https://doi.org/10.1016/j.jgar.2020.06.005.

APA

Fang, R., Sun, Y., Dai, W., Zheng, X., Tian, X., Zhang, X., Wang, C., Cao, J., & Zhou, T. (2020). Mutations in the MepRAB efflux system contribute to the in vitro development of tigecycline resistance in Staphylococcus aureus. Journal of Global Antimicrobial Resistance, 22, 631–636. https://doi.org/10.1016/j.jgar.2020.06.005

Chicago

Fang, Renchi, Yao Sun, Weisi Dai, Xiangkuo Zheng, Xuebin Tian, Xiucai Zhang, Chong Wang, Jianming Cao, and Tieli Zhou. 2020. “Mutations in the MepRAB Efflux System Contribute to the in Vitro Development of Tigecycline Resistance in Staphylococcus Aureus.” Journal of Global Antimicrobial Resistance 22 (September): 631–36. doi:10.1016/j.jgar.2020.06.005.